Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 62 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 7838216

    Human gene related to but distinct from EGF receptor gene

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  2. US 7838531

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 23, 2010 · Expires Nov 18, 2030

    granted

  3. US 7834005

    Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  4. US 7833533

    Enhanced antiviral activity against foot and mouth disease

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 16, 2010 · Expires Nov 11, 2030

    granted

  5. US 7829102

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted

  6. US 7825216

    Phenylanine derivatives

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  7. US 7824682

    Cardiac myosin light chain kinase-specific antibodies and methods of detecting

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  8. US 7824690

    Marek's disease virus vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  9. US 7824695

    Delivery of proteins across polar epithelial cell layers

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  10. US 7825096

    O6-alkylguanine-DNA alkyltransferase inactivators and beta-glucuronidase cleavable prodrugs

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  11. US 7825126

    Purine derivatives as A3 and A1 adenosine receptor agonists

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  12. US 7824681

    Human monoclonal antibodies that specifically bind IGF-II

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted

  13. US 7820642

    Nandrolone 17β-carbonates

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  14. US 7820174

    T cell receptors and related materials and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  15. US 7820181

    Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  16. US 7820182

    Production of attenuated, human-bovine chimeric respiratory syncytial viruses for use in immunogenic compositions

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted

  17. US 7816087

    Gene expressed in prostate cancer and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  18. US 7815916

    Cloning and expression of HTLV-III DNA

    The United States of America, as represented by the Secretary, Health and Human Services · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted

  19. US 7811998

    Novobiocin analogues as anticancer agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted

  20. US 7812117

    Vasostatin as marrow protectant

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 12, 2010 · Expires Oct 7, 2030

    granted

  21. US 7807805

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  22. US 7803380

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  23. US 7803913

    Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  24. US 7803614

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.